Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: S-Allylcysteine and Doxorubicin Hydrochloride

Research Papers that Mention the Interaction

Manuscript reports a number of constituents with evident potential in prevention of DOX cardiotoxicity e.g. proanthocyanidins, epigallocatechin-3-gallate, S-allylcysteine , reseveratrol, rutoside etc.
Current clinical pharmacology  •  2014  |  View Paper
Doxorubicin injection induced a mortality rate of 58%, with SAC treatment reducing the doxorubicin-induced mortality rate to 30%.
The severe body weight loss caused by doxorubicin (13%) was also significantly attenuated by SAC treatment (9%).
These results suggest that SAC research may ultimately lead to a resolution of the adverse effects of doxorubicin treatment in cancer chemotherapy.
Planta medica  •  2000  |  View Paper